About Dechra Pharmaceuticals (LON:DPH)
Dechra Pharmaceuticals plc develops, manufactures, sells, and markets veterinary pharmaceuticals and related products for veterinarians worldwide. The company operates through the European Pharmaceuticals, the North American Pharmaceuticals, and the Pharmaceuticals Research and Development segments. It offers various endocrinology, dermatology and care, anesthesia and analgesia, cardiovascular disease, ophthalmology, and equine medicine products; food producing animal antimicrobials; poultry vaccines; and pet diets. The company markets and distributes veterinary pharmaceuticals and equipment; provides financial services; and manufactures human and veterinary pharmaceutical products for third party customers. Dechra Pharmaceuticals plc markets its products through wholesaler and distributor networks. The company was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolLON:DPH
CUSIPN/A
Phone+44-1606-814730
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins7.15%
Return on Equity9.08%
Return on Assets4.25%
Miscellaneous
EmployeesN/A
Outstanding Shares93,420,000
Dechra Pharmaceuticals (LON:DPH) Frequently Asked Questions
What is Dechra Pharmaceuticals' stock symbol?
Dechra Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "DPH."
How often does Dechra Pharmaceuticals pay dividends? What is the dividend yield for Dechra Pharmaceuticals?
Dechra Pharmaceuticals announced a dividend on Monday, February 26th. Shareholders of record on Thursday, March 8th will be paid a dividend of GBX 7.33 per share on Friday, April 6th. This represents a yield of 0.29%. The ex-dividend date of this dividend is Thursday, March 8th. The official announcement can be accessed at this link. View Dechra Pharmaceuticals' Dividend History.
What price target have analysts set for DPH?
6 brokers have issued 1 year price targets for Dechra Pharmaceuticals' stock. Their predictions range from GBX 1,550 to GBX 2,640. On average, they expect Dechra Pharmaceuticals' stock price to reach GBX 2,121.17 in the next twelve months. View Analyst Ratings for Dechra Pharmaceuticals.
Who are Dechra Pharmaceuticals' key executives?
Dechra Pharmaceuticals' management team includes the folowing people:
- Mr. Ian D. Page, CEO, MD & Exec. Director (Age 57)
- Mr. Richard John Cotton BA Hons, FCMA, CFO & Director (Age 57)
- Dr. Anthony Gerard Griffin, MD of Dechra Veterinary Products for Europe & Exec. Director (Age 55)
- Ms. Andrea Dodds, Group Marketing Director
- Ms. Katy Clough, Group HR Director
Has Dechra Pharmaceuticals been receiving favorable news coverage?
News articles about DPH stock have trended somewhat positive on Wednesday, Accern Sentiment reports. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Dechra Pharmaceuticals earned a news sentiment score of 0.16 on Accern's scale. They also gave media headlines about the company an impact score of 46.95 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
How do I buy shares of Dechra Pharmaceuticals?
Shares of DPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Dechra Pharmaceuticals' stock price today?
One share of DPH stock can currently be purchased for approximately GBX 2,786.
How big of a company is Dechra Pharmaceuticals?
Dechra Pharmaceuticals has a market capitalization of £2.73 billion.
How can I contact Dechra Pharmaceuticals?
Dechra Pharmaceuticals' mailing address is 24 Cheshire Business Park Cheshire Avenue, NORTHWICH, CW9 7UA, United Kingdom. The company can be reached via phone at +44-1606-814730.
MarketBeat Community Rating for Dechra Pharmaceuticals (DPH)
MarketBeat's community ratings are surveys of what our community members think about Dechra Pharmaceuticals and other stocks. Vote "Outperform" if you believe DPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
Dechra Pharmaceuticals (LON:DPH) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
6 Wall Street analysts have issued ratings and price targets for Dechra Pharmaceuticals in the last 12 months. Their average twelve-month price target is GBX 2,121.17The high price target for DPH is GBX 2,640 and the low price target for DPH is GBX 1,550. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.50 | 2.50 | 2.50 | 2.50 |
| Ratings Breakdown: | 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | GBX 2,121.17 | GBX 2,121.17 | GBX 1,904.50 | GBX 1,784 |
Dechra Pharmaceuticals (LON:DPH) Consensus Price Target History
Dechra Pharmaceuticals (LON:DPH) Analyst Ratings History
Show:
(Data available from 4/25/2016 forward)
Dechra Pharmaceuticals (LON:DPH) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/26/2018 | | GBX 7.33 | 0.29% | 3/8/2018 | 3/8/2018 | 4/6/2018 |
| 9/4/2017 | | GBX 15.33 | 0.74% | 10/26/2017 | 10/26/2017 | 11/17/2017 |
| 2/27/2017 | | GBX 6.11 | 0.38% | 3/9/2017 | 3/9/2017 | 4/7/2017 |
| 9/5/2016 | | GBX 12.91 | 0.92% | 10/27/2016 | 10/27/2016 | 11/18/2016 |
| 2/22/2016 | | GBX 5.55 | 0.47% | 3/10/2016 | 3/10/2016 | 4/6/2016 |
| 9/7/2015 | | GBX 11.82 | 1.26% | 10/29/2015 | 10/29/2015 | 11/20/2015 |
| 9/8/2014 | | GBX 10.65 | 1.4% | 11/6/2014 | 11/6/2014 | 11/21/2014 |
| 2/25/2014 | | GBX 4.75 | 0.68% | 3/12/2014 | 3/12/2014 | 4/8/2014 |
(Data available from 1/1/2013 forward)
Dechra Pharmaceuticals (LON DPH) Insider Trading and Institutional Ownership History
Dechra Pharmaceuticals (LON DPH) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 9/19/2017 | Ian Page | Insider | Sell | 54,910 | GBX 2,024 | £1,111,378.40 | | |
| 6/21/2017 | Ian Page | Insider | Sell | 134,500 | GBX 1,927 | £2,591,815 | | |
| 5/2/2017 | Ian Page | Insider | Sell | 1,630 | GBX 1,715 | £27,954.50 | | |
| 3/21/2017 | Tony Griffin | Insider | Sell | 3,500 | GBX 1,676 | £58,660 | | |
| 11/30/2016 | Tony Griffin | Insider | Sell | 17,133 | GBX 1,292 | £221,358.36 | | |
| 6/3/2016 | Rice,Tony | Insider | Buy | 20,000 | GBX 1,141 | £228,200 | | |
| 3/21/2016 | Nesmes,Anne-Francoise | Insider | Sell | 3,100 | GBX 1,208 | £37,448 | | |
| 9/9/2015 | Nesmes,Anne-Francoise | Insider | Sell | 18,319 | GBX 940 | £172,198.60 | | |
(Data available from 1/1/2013 forward)
Dechra Pharmaceuticals (LON DPH) News Headlines
| Source: |
|
Dechra Pharmaceuticals (LON:DPH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Dechra Pharmaceuticals (LON DPH) Stock Chart for Wednesday, April, 25, 2018
Loading chart…
